Techno Drugs Statistics

Total Valuation

Techno Drugs has a market cap or net worth of BDT 3.70 billion. The enterprise value is 5.86 billion.

Market Cap	3.70B
Enterprise Value	5.86B

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	Nov 19, 2024

Share Statistics

Techno Drugs has 132.00 million shares outstanding. The number of shares has increased by 21.18% in one year.

Current Share Class	n/a
Shares Outstanding	132.00M
Shares Change (YoY)	+21.18%
Shares Change (QoQ)	+6.64%
Owned by Insiders (%)	66.79%
Owned by Institutions (%)	n/a
Float	37.84M

Valuation Ratios

The trailing PE ratio is 14.61.

PE Ratio	14.61
Forward PE	n/a
PS Ratio	1.23
PB Ratio	0.94
P/TBV Ratio	0.94
P/FCF Ratio	n/a
P/OCF Ratio	10.97
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.15, with an EV/FCF ratio of -13.69.

EV / Earnings	26.80
EV / Sales	1.96
EV / EBITDA	6.15
EV / EBIT	10.01
EV / FCF	-13.69

Financial Position

The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.66.

Current Ratio	2.03
Quick Ratio	1.02
Debt / Equity	0.66
Debt / EBITDA	2.73
Debt / FCF	-6.09
Interest Coverage	1.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	10.41%
Revenue Per Employee	1.77M
Profits Per Employee	129,125
Employee Count	1,694
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	32.75
200-Day Moving Average	n/a
Relative Strength Index (RSI)	18.58
Average Volume (20 Days)	403,623

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Techno Drugs had revenue of BDT 2.99 billion and earned 218.74 million in profits. Earnings per share was 1.92.

Revenue	2.99B
Gross Profit	1.30B
Operating Income	585.34M
Pretax Income	258.64M
Net Income	218.74M
EBITDA	925.58M
EBIT	585.34M
Earnings Per Share (EPS)	1.92

Full Income Statement

Balance Sheet

The company has 440.26 million in cash and 2.61 billion in debt, giving a net cash position of -2.17 billion or -16.41 per share.

Cash & Cash Equivalents	440.26M
Total Debt	2.61B
Net Cash	-2.17B
Net Cash Per Share	-16.41
Equity (Book Value)	3.95B
Book Value Per Share	29.91
Working Capital	1.66B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 337.03 million and capital expenditures -765.23 million, giving a free cash flow of -428.20 million.

Operating Cash Flow	337.03M
Capital Expenditures	-765.23M
Free Cash Flow	-428.20M
FCF Per Share	-3.24

Full Cash Flow Statement

Margins

Gross margin is 43.30%, with operating and profit margins of 19.56% and 7.31%.

Gross Margin	43.30%
Operating Margin	19.56%
Pretax Margin	8.64%
Profit Margin	7.31%
EBITDA Margin	30.93%
EBIT Margin	19.56%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 4.17%.

Dividend Per Share	1.20
Dividend Yield	4.17%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-21.18%
Shareholder Yield	-17.01%
Earnings Yield	5.92%
FCF Yield	-11.59%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Techno Drugs has an Altman Z-Score of 2.05. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.05
Piotroski F-Score	n/a